Stephanie M Pouch
Overview
Explore the profile of Stephanie M Pouch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beechar V, Pouch S, La Hoz R
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae670.
PMID: 39620107
The prevalence of donor-derived Bartonella quintana infection poses an emerging issue in solid organ transplantation. Further studies are needed to validate criteria for donor screening to prevent transmission without negatively...
2.
Lee D, Abidi M, Fisher C, Hughart A, Toda M, Williams S, et al.
Transpl Infect Dis
. 2024 Nov;
27(1):e14406.
PMID: 39603983
Background: Coccidioidomycosis is a fungal infection that poses a serious risk when transmitted through organ transplantation. We analyzed cases reported to the Organ Procurement and Transplantation Network ad hoc Disease...
3.
Pouch S, Anesi J, Pruett T, Harmon M, Dionne S, Hasz R, et al.
Transpl Infect Dis
. 2024 Nov;
27(1):e14407.
PMID: 39603978
Background: Donor screening and antimicrobial management processes are inconsistent across organ procurement organizations (OPOs) and transplant centers. As part of a Controversies Conference addressing the evaluation and management of infectious...
4.
Beechar V, Phadke V, Pouch S, Mehta A, Karadkhele G, Larsen C, et al.
Clin Transplant
. 2024 Oct;
38(10):e15480.
PMID: 39427300
Introduction: Maribavir was recently approved by the FDA, expanding treatment options for post-solid-organ transplant refractory/resistant CMV. We sought to describe the post-marketing experience with maribavir at a large academic transplant...
5.
Waller K, Pouch S
Transpl Infect Dis
. 2024 Sep;
26 Suppl 1:e14380.
PMID: 39312246
No abstract available.
6.
Eichenberger E, Phadke V, Busch L, Pouch S
Infect Dis Clin North Am
. 2024 Sep;
38(4):693-712.
PMID: 39261138
Patients on mechanical circulatory support are at heightened risk for infection given the invasive nature of the devices with internal and external components, the surgical implantation of the devices, and...
7.
Te H, Lee D, Woolley A, Abidi M, Fisher C, Sellers M, et al.
Transpl Infect Dis
. 2024 Jun;
26 Suppl 1:e14305.
PMID: 38881210
Background: Better access to direct-acting antiviral (DAA) therapy has broadened the utilization of hepatitis C virus (HCV) nucleic acid testing (NAT) positive organs with excellent outcomes. However, DAA therapy has...
8.
Eichenberger E, Donzo M, Anderson R, Karadkhele G, Pouch S, Larsen C
Clin Transplant
. 2024 Mar;
38(3):e15279.
PMID: 38485657
Background: Bacteriuria is common among kidney transplant recipients (KTR). Risk factors and outcomes associated with bloodstream infection due to a urinary source (BSIU) in KTR are poorly understood. Methods: This...
9.
Babiker A, Karadkhele G, Bombin A, Watkins R, Robichaux C, Smith G, et al.
Open Forum Infect Dis
. 2024 Mar;
11(3):ofae060.
PMID: 38464488
Background: Reducing the burden of multidrug-resistant organism (MDRO) colonization and infection among renal transplant recipients (RTRs) may improve patient outcomes. We aimed to assess whether the detection of an MDRO...
10.
Pouch S, La Hoz R
Am J Transplant
. 2024 Feb;
24(7):1327-1328.
PMID: 38423511
No abstract available.